Fund-Utilization (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SEBI issues interim order against Nirman Agri Genetics Limited and Pranav Kailas Bagal regarding IPO proceeds utilization irregularities. | |||||||||||||||
SEBI issues interim order against Nirman Agri Genetics Limited and Pranav Kailas Bagal regarding IPO proceeds utilization irregularities.
| |||||||||||||||
SEBI restrains Nirman Agri Genetics Limited from accessing securities market and restricts Pranav Kailas Bagal from trading in the scrip … | |||||||||||||||
SEBI restrains Nirman Agri Genetics Limited from accessing securities market and restricts Pranav Kailas Bagal from trading in the scrip pending investigation into IPO fund utilization.
| |||||||||||||||
SEBI issues interim order against Nirman Agri Genetics Limited and Pranav Kailas Bagal examining alleged irregularities in IPO fund … | |||||||||||||||
SEBI issues interim order against Nirman Agri Genetics Limited and Pranav Kailas Bagal examining alleged irregularities in IPO fund utilization following listing on NSE SME platform in March 2023.
| |||||||||||||||
Amendment to Series II Debentures issue size increased from INR 750 Crores to INR 840 Crores and revised end use of proceeds for … | |||||||||||||||
Amendment to Series II Debentures issue size increased from INR 750 Crores to INR 840 Crores and revised end use of proceeds for construction projects.
| |||||||||||||||